Lisa McChesney-Harris, PhD, CEO and FounderFounded in 2011 by Lisa McChesney-Harris, PhD, Prompt Praxis Laboratories (PPL) has built a stellar reputation by delivering high-quality analytical testing services tailored to meet the needs of the pharmaceutical, veterinary, and wellness industries. What sets the company apart from others in the analytical testing space is its unique blend of technological innovation, scientific rigor, and a commitment to customer service.
Headquartered in Vernon Hills, IL, Prompt Praxis Laboratories was conceived out of Lisa McChesney-Harris’s frustration with the inefficiencies she encountered working with third-party laboratories. Time and again, she noticed recurring problems—sluggish turnaround times, inconsistent data quality, a lack of transparency, and ever-escalating project costs. These challenges were not just operational but also had a direct impact on the regulatory compliance and market readiness of pharmaceutical products.
“I knew the industry needed something better,” McChesney-Harris explains. “We saw an opportunity to build a laboratory from the ground up that would eliminate these common pitfalls. It had to be fast, reliable, transparent, and focused on regulatory excellence.”
A Vision for Excellence in Pharmaceutical Testing
PPL’s approach has always been centered on innovation, efficiency, and operational excellence. From its inception, the company set out to solve the issues that plagued traditional laboratories, especially in the fast-paced and ever-changing pharmaceutical sector.
Regulatory changes are not just hurdles—they’re opportunities to innovate
Unlike many labs that rely on paper-based documentation, PPL adopted the NuGenesis Laboratory Management System (LMS) early on, which allowed them to shift to a completely digital and integrated workflow. This move not only improved efficiency but also enabled real-time data capture and seamless integration of testing processes, resulting in faster turnaround times and a higher level of compliance with regulatory standards.
The adoption of digital infrastructure was only the beginning of PPL’s journey. The company also implemented ultra-performance liquid chromatography (UPLC) and Waters' Empower software, two key components that allow them to achieve precise and rapid analytical testing across a broad range of compounds. With these tools, PPL ensures that all tests, whether for compounded sterile preparations (CSPs), generic injectables, or veterinary products, meet the highest standards of accuracy and reliability.
“We knew from the start that technology would be a key differentiator,” says McChesney-Harris. “But technology alone isn’t enough. We had to create a culture of excellence where every member of the team was aligned with our mission to provide top-tier service, no excuses.”
Adapting to Market Shifts and Regulatory Changes
In the early years of its existence, PPL focused primarily on developing chemistry, manufacturing, and control (CMC) programs for generic drugs. However, the company’s adaptability became evident in 2013, when the U.S. Food and Drug Administration (FDA) introduced stricter regulations for compounded pharmaceuticals in response to a national meningitis outbreak. This regulatory shift created significant challenges for pharmaceutical manufacturers and compounding pharmacies.
In a pivotal move, PPL shifted its focus to the burgeoning 503B outsourcing market, where heightened regulatory scrutiny was reshaping demand. Prioritizing compliance, PPL’s team worked diligently to tailor its services to meet the specific needs of compounded sterile preparations (CSPs), which required an additional layer of testing and validation to meet new FDA expectations.
“Regulatory changes are not just hurdles—they’re opportunities to innovate,” McChesney-Harris explains. “We embraced the shift and built the infrastructure to support the changing needs of the industry. The 503B market presented a unique challenge, but we were able to quickly pivot and meet the new regulatory requirements with precision.”
Today, PPL serves a broad array of industries, offering analytical testing for everything from generic injectables to veterinary and wellness products. With more than 45 scientists, technicians, and regulatory experts, Prompt Praxis Laboratories has positioned itself as a trusted partner for clients navigating complex regulatory environments. The company’s testing services include analytical development, method validation, stability studies, and rapid sterility and bacterial endotoxin testing (BET), among others.
“The Ready-to-Analyze® platform is one of the ways we’ve made testing more accessible and efficient,” says McChesney-Harris. “Our clients don’t need to wait for months to validate testing methods; they can start their programs immediately, saving both time and money. This speeds up their time to market and also provides them with the regulatory confidence they need.”
The Ready-to-Analyze® Platform
A major milestone for PPL came with the introduction of its Ready-to-Analyze® platform. This innovative service allows clients to bypass the usual method validation process, which can be both time-consuming and costly. Through this platform, the company provides pre-validated testing methods for common molecules, enabling clients to initiate testing almost immediately.
-
We saw an opportunity to build a laboratory from the ground up that would eliminate these common pitfalls. It had to be fast, reliable, transparent, and focused on regulatory excellence
“The Ready-to-Analyze® platform is one of the ways we’ve made testing more accessible and efficient,” says McChesney-Harris. “Our clients don’t need to wait for months to validate testing methods; they can start their programs immediately, saving both time and money. This speeds up their time to market and also provides them with the regulatory confidence they need.”
The platform has become an essential tool for many of PPL’s clients, enabling them to streamline their testing processes and reduce the cost of product development. By maintaining a portfolio of validated methods, PPL empowers clients to bypass the typically expensive and lengthy validation steps required for common molecules, ultimately accelerating product timelines and reducing the risk of delays.
Committed to Proactive Communication and Transparency
What truly distinguishes PPL from other industry players is its operational agility. At the core of its success is the company’s ability to balance cutting-edge technology with a high-touch customer service approach. PPL’s team doesn’t just run tests; they work hand-in-hand with clients to develop customized solutions, anticipate challenges, and ensure regulatory compliance at every stage of the process.
“Our team operates with a single mission: to provide the best service, every time,” McChesney-Harris says. “That means understanding not only the scientific side of testing but also the pressures and challenges our clients face in the market. We proactively address potential issues, ensuring that our clients can move forward with confidence.”
This customer-first philosophy permeates every aspect of PPL’s operations. The lab offers concierge onboarding, transparent pricing, and clear communication at every step of the testing process.
PPL’s commitment to proactive communication and transparency is a key factor in its ability to build long-term relationships with clients. The company’s reputation for reliability has led to many referrals from satisfied clients, with some even returning to PPL after negative experiences with other laboratories.
One such instance involved a client who had fallen behind schedule with a critical product development. They turned to PPL for help, and within just a few days, the lab delivered the necessary test results, allowing the client to meet their deadlines. This level of responsiveness is rare in the industry, where delays and miscommunications can have serious consequences.
Driven by Regulatory Foresight, Defined by Precision
In the pharmaceutical testing world, regulatory compliance is non-negotiable. PPL takes this responsibility seriously and its commitment to meeting regulatory requirements is embedded in everything it does. PPL is committed to maintaining current good manufacturing practices (cGMP) at all stages of its testing process, ensuring that all results are reproducible, reliable, and defensible in the face of regulatory scrutiny.
“We understand that every test we perform has to stand up to scrutiny from both our clients and the regulatory bodies that oversee their operations,” says McChesney-Harris. “Our dual-customer mindset means we are constantly thinking about the needs of both our clients and the regulators who hold them accountable.”
This commitment to regulatory foresight has helped PPL avoid a significant issue that many laboratories face: contributing to an FDA Form 483 observation. To date, PPL has maintained an unblemished record in this area, a testament to its meticulous approach to compliance and quality control.
“We never lose sight of the fact that our work impacts not just our clients, but also the regulatory authorities that oversee their operations,” McChesney-Harris notes. “That’s why we approach every analysis with both scientific rigor and regulatory awareness. Our clients can be confident that their results will meet or exceed the highest standards.”
A Future Built on Partnerships
Looking ahead, PPL is poised to continue its growth and innovation in the analytical testing space. The company has recently begun an expansion of its laboratory facility. This project will add an additional 8,100 sq ft to its current operations and is expected to be completed by the first quarter of 2026. This expansion reflects PPL’s continued growth and commitment to supporting clients with increased capacity and enhanced capabilities.
As the pharmaceutical industry faces ever-evolving regulatory challenges and increased demand for outsourced testing services, PPL’s ability to remain flexible, responsive, and technologically advanced positions it as a leader in the industry.
“Our clients are our partners, and our success is tied to their success,” says McChesney-Harris.
As PPL moves forward, its commitment to excellence in every aspect of its operations—from scientific rigor to customer service and regulatory compliance—will continue to shape the future of analytical testing in the pharmaceutical industry. The company’s story is one of innovation, purpose, and a deep-seated dedication to the success of its clients. And for McChesney-Harris and her team, it’s just the beginning.
“We’re not just meeting the moment,” she says with conviction. “We’re shaping the future of pharmaceutical testing. And we’re doing it one partnership at a time.”
Choosing Analytical Laboratory Testing That Stands Up to Scrutiny
Life science companies do not engage analytical laboratory testing services simply to generate data. These organizations use laboratories in order to make decisions regarding their products, plan the timelines for releasing their products, and avoid any unnecessary gaps in their products' reviews. For pharmaceutical firms, compounding pharmacies and medical device firms, the relationship with the lab is often a silent but essential part of the business that keeps the whole thing moving forward. A missed turnaround can impact production planning; a non-conforming method can prompt questions that may lead to an unexpected delay in filings, investigations or batch release; poor documentation, for example, can mean management has to defend their science rather than use it with confidence in advancing development or release.
The strongest laboratory partners combine scientific rigor with disciplined operational responsiveness. Fast turnaround times only create value when supported by controlled methods, traceable documentation, and results capable of withstanding regulatory inspection. When comparing vendors, executives should go beyond broad pronouncements of speed and examine how consistently a lab operates under high-stress conditions like high volume, new formulation or short staffing. A reliable lab will neither rest on personal labor alone but operate steadily with systems and multi-trained employees.
Regulatory awareness is equally important. Analytical testing is not a stand-alone scientific process; it takes place under the regulatory context of FDA regulations, state boards of pharmacy regulations, internal quality management systems, and risk assessment of products. The laboratory that understands this context may well be in a position to forecast anticipated regulatory queries before they become formal findings. What this indicates is that a laboratory recognizes the fact that there's more than a standard procedure in assay development, stability studies, impurity characterization, container compatibility studies or methods validation. For purchasers, the ability of the laboratory to perform the test is less significant than its ability to assist in making sure the data meets the regulatory or operational decisions to be made.
Method capability is another important indicator of maturity. Pharmaceutical and compounded preparation testing frequently involves complex formulations, multi-component products, and stability considerations that cannot be addressed through generic testing templates. Good labs can adjust methods for the molecular structure, concentration, range, the dosage form and the required clinical application while maintaining reproducibility and defensibility. Good labs know that the work and the science must progress together. It is possible to cut the cost and turn around time if we can cut the run times, do components in parallel or have validated streamlined workflows as long as the science is strong enough to be reviewed, transferred and re-applied.
Strongest analytical partners also collaborate better with executive leadership and quality. They proactively communicate, know potential regulatory flashpoints and present testing not as a discrete transaction but as a necessary component on the road to product quality and compliance. Those partnerships deliver not just lab results but the certainty that a release decision, a development process or an investigation response has a solid evidentiary basis.
For organizations evaluating analytical laboratory testing support, Prompt Praxis Labs represents a strong option where speed, regulatory confidence, and method discipline must coexist. The company’s capabilities align closely with pharmaceutical products and compounded sterile and nonsterile preparations, including analytical testing, analytical development and validation, formulation development, rapid sterility and BET testing, stability studies, batch release potency and identification testing, method transfer support, and Ready-to-Analyze® methods for strength, quality and identity assessment. Prompt Praxis Labs is a viable partner for life science organizations looking for rapid delivery while maintaining review-ready scientific integrity due to its focus on transparency, phased staffing models, forward-thinking regulations and decisive action.
...Read more
Analytical Laboratory Testing Service Info
Q1
Why is Prompt Praxis Laboratories recognized among top Analytical Laboratory Testing Services providers?
Prompt Praxis Laboratories has earned recognition in Analytical Laboratory Testing Services through its emphasis on speed, precision, and regulatory alignment in pharmaceutical testing. The company supports pharmaceutical manufacturers, compounding pharmacies, and healthcare organizations with rapid analytical testing, stability studies, and validation services designed to ensure product quality and compliance. Its reputation is reinforced by a digitally integrated laboratory model that improves turnaround times while maintaining high data integrity standards. This combination of operational efficiency and scientific rigor has positioned it as a trusted partner in regulated pharmaceutical environments.
Q2
What differentiates Prompt Praxis Laboratories in Analytical Laboratory Testing Services?
A defining strength of Prompt Praxis Laboratories lies in its integration of advanced laboratory technologies and streamlined digital systems within Analytical Laboratory Testing Services. It operates with modern analytical platforms such as chromatography systems and laboratory management software that enable real-time data capture and faster reporting cycles. The company also developed its Ready-to-Analyze® framework, which provides pre-validated test methods that reduce method development delays and accelerate product testing timelines. This approach helps clients move from sample submission to actionable results with greater efficiency and consistency.
Q3
How does Prompt Praxis Laboratories support pharmaceutical and compounding pharmacy clients?
Support for pharmaceutical and compounding pharmacy clients is central to Prompt Praxis Laboratories’ Analytical Laboratory Testing Services model. It delivers a wide range of services including batch release testing, stability studies, sterility testing, endotoxin testing, impurity profiling, and method validation support. The laboratory works closely with clients to address product-specific requirements, ensuring that each testing protocol aligns with regulatory expectations and intended product use. Its collaborative approach helps organizations maintain compliance while improving development speed and product reliability.
Q4
How does the company ensure accuracy and regulatory compliance in testing?
Accuracy and compliance are embedded throughout Prompt Praxis Laboratories’ Analytical Laboratory Testing Services through validated methodologies, standardized workflows, and strict adherence to pharmaceutical regulatory frameworks. The laboratory operates under structured quality systems that support reproducibility and traceability of results across all testing phases. Its validation processes include method development, stability-indicating assays, and forced degradation studies that ensure analytical robustness. This disciplined framework enables clients to rely on consistent, defensible data for regulatory submissions and internal decision-making.
Q5
What role does innovation play in Prompt Praxis Laboratories’ testing approach?
Innovation is a core driver of Prompt Praxis Laboratories’ Analytical Laboratory Testing Services, particularly through its adoption of digital laboratory infrastructure and rapid testing methodologies. The company integrates technology-enabled workflows that reduce manual inefficiencies and improve communication across testing stages. Its Ready-to-Analyze® platform exemplifies this innovation by offering pre-validated methods that shorten development cycles and enhance operational predictability. This focus on modernization allows the laboratory to adapt quickly to evolving pharmaceutical testing demands.
Q6
Why is Prompt Praxis Laboratories relevant to modern pharmaceutical development needs?
Prompt Praxis Laboratories remains highly relevant in Analytical Laboratory Testing Services due to increasing industry pressure for faster development timelines, stricter regulatory oversight, and higher product complexity. Its ability to combine rapid testing capabilities with regulatory-grade validation supports pharmaceutical companies navigating accelerated product pipelines. The laboratory’s emphasis on transparency, data integrity, and responsive client communication strengthens its role as a dependable partner in drug development and quality assurance workflows.
